When every day you see how much in our world there are imperfections and sufferings, I want to direct all my capabilities and knowledge to help and solve these complex tasks. It is important to believe in yourself and trust your inner feelings. When there is a goal, you need to go to it without folding. Our fund is engaged in the search and implementation of promising medical projects. Most real projects are really important and necessary, and philanthropists will only benefit from the introduction of new technologies that make life for all people more comfortable and safer.
The main objective of the fund is to search for investors and benefactors to attract financial resources for really necessary and socially significant projects and tasks on a global scale. Without financial assistance, many projects can not be implemented at all. The financial assistance of our foundation is a very important and necessary step for the successful creation of projects.
Project support allows to study the project in detail in order to provide independent data and strategic recommendations to philanthropists and investors on project implementation, project costs, risk and purchase models and asset valuation at any stage of the project.
Support for research and development significantly affects the prospects and opportunities for the growth of various projects, for example in the pharmaceutical industry. In our fund there is a program to support the research of medicines and pharmaceuticals. This program is aimed at expanding the capabilities in the development of new drugs and medical systems.
The Charity Fund "Sihtasutus Charity Fund" was established in 2017. The Foundation carries out its activities on voluntary donations of individuals and businesses. MISSION OF CHARITY FUND "Sihtasutus Charity Fund": for the development of innovative and socially significant medicine, provision of gratuitous aid to hospitals, medical centers, financing of research and development of innovative drugs and medical systems and their production.
The specifics of emergency medicine imposes special requirements upon the quality and timeliness of hemostasis. The presentation will show the characteristics of local hemostatic agents (LHA), i.e. drugs aimed at stopping bleedings. It will also envisage classification, the mechanisms of action, and the evidence of the effectiveness of the main types of hemostatic agents both of domestic and foreign production.